Characterization of ANKRA, a Novel Ankyrin Repeat Protein That Interacts with the Cytoplasmic Domain of Megalin

Total Page:16

File Type:pdf, Size:1020Kb

Load more

ARTICLES J Am Soc Nephrol 11: 2167–2178, 2000 Characterization of ANKRA, a Novel Ankyrin Repeat Protein that Interacts with the Cytoplasmic Domain of Megalin KATHERINE RADER,* ROBERT A. ORLANDO,† XIAOJING LOU,* AND MARILYN GIST FARQUHAR*† Departments of *Cellular and Molecular Medicine and †Pathology, University of California San Diego, La Jolla, California. Abstract. Ankyrin-repeat family A protein (ANKRA) is a unique. By cell fractionation, ANKRA is found both in the novel protein that interacts directly and specifically with the cytosol and associated with membranes enriched in megalin in cytoplasmic tail of megalin in the yeast two-hybrid system and L2 cells and proximal tubule cells. By immunofluorescence, glutathione-S-transferase pull-down assays. ANKRA has three ANKRA is concentrated near megalin along the plasma mem- ankyrin repeats and shows 61% overall homology to regulatory brane of L2 cells and in the kidney cortex is expressed in factor X, ankyrin repeat-containing protein. Mapping studies glomerular and proximal tubule epithelia which also express show that the three ankyrin repeats and C-terminus of ANKRA megalin. These observations suggest that ANKRA may play a are required for binding to a unique juxtamembrane, 19-amino unique role in megalin’s function as a clearance receptor in the acid sequence on the megalin tail. Point mutational analysis kidney and L2 cells. In addition, ANKRA may have other reveals that a proline-rich motif (PXXPXXP) within this region partners because northern blot analysis reveals that ANKRA is is the site of ANKRA binding. ANKRA interacts with megalin more broadly expressed than megalin, and by immunofluores- but not with low-density lipoprotein receptor related protein, in cence ANKRA is also expressed in connecting tubule cells and keeping with the fact that the sequence of the megalin tail is principal cells of collecting ducts. Megalin (approximately 600 kD), a member of the low-density families, plasminogen, lactoferrin, thyroglobulin, Ca2ϩ, and lipoprotein receptor (LDLR) superfamily, is found in clathrin- receptor-associated protein (RAP), a chaperone for members of coated vesicles in glomerular and proximal tubule epithelial the LDLR gene family (1,3). cells of the kidney (1). Recent studies show that megalin is the Although considerable work has been done on ligand bind- main endocytic receptor in the proximal tubule and specifically ing to the extracellular domain of megalin, the role of its binds and internalizes a number of proteins that are filtered by cytoplasmic domain in regulating megalin’s endocytic or exo- the glomerulus (2,3). These proteins include insulin (2); apo- cytic trafficking pathways (1,6) or putative Ca2ϩ-sensing func- lipoprotein H/I complexes; carriers for vitamins D3,B12, and A tion (7) is completely unknown. Megalin has a unique cyto- (retinol); and parathyroid hormone, among others (3,4). Mega- plasmic tail that shows little sequence similarity to other LDLR lin knockout mice exhibit proximal tubule reabsorption defi- family members except for conserved NPXY motifs (8). The ciency and a significant reduction in the number and size of fact that the cytoplasmic tail of receptors regulates their traf- organelles (clathrin-coated pits, endosomes, dense apical tu- ficking and signaling suggests that megalin has trafficking bules, and lysosomes) associated with endocytosis in the prox- itineraries or intracellular signaling pathways distinct from imal tubule (3,4). Thus, megalin expression is directly corre- those of other LDLR family members. The presence of lated with endocytic activity in the proximal tubule. In other dileucine, YXXØ, PXXP, and (S/T)XV motifs as well as systems, megalin has been shown to bind a number of other NPXY motifs, provides clues to the function of the megalin tail ligands from the lipoprotein and protease/protease inhibitor (7,8). Tyrosine-based motifs (NPXY, YXXØ) and dileucine motifs serve to direct receptors to clathrin-coated pits for rapid internalization or sorting within the trans-Golgi network by binding selectively to adaptor proteins AP-1, AP-2, or AP-3 Received February 22, 2000. Accepted May 30, 2000. Data deposition: The sequences reported in this article have been deposited in (9–11). This is in keeping with the fact that megalin, like other the GenBank database (Accession nos. hANKRA, AF314032; mANKRA, members of the LDL family, is internalized via clathrin-coated AF314031). pits (1,6,12). PXXP motifs bind to SH3 domains, (S/T)XV to Correspondence to Dr. Marilyn Gist Farquhar, Department of Cellular and PDZ domains, NPXY to PTB domains, and YXXØ to SH2 Molecular Medicine, University of California San Diego, 9500 Gilman Drive, domains (13). These interactions have been shown to be im- La Jolla, CA 92093-0651. Phone: 858-534-7711; Fax: 858-534-8549; E-mail: [email protected] portant for subcellular localization (14,15), endocytic traffick- 1046-6673/1112-2167 ing (16–19), and signaling (13–15,20) of some transmembrane Journal of the American Society of Nephrology proteins. However, nothing is known concerning the functions Copyright © 2000 by the American Society of Nephrology or molecular interactions of these motifs in the case of megalin. 2168 Journal of the American Society of Nephrology J Am Soc Nephrol 11: 2167–2178, 2000 To gain insight into the interactions of the megalin tail and in 10% fetal calf serum (Life Technologies, BRL, Grand Island, NY), thereby into megalin’s functions, we used the two-hybrid sys- MEM-alpha medium (Irvine Scientific, Santa Ana, CA). tem to identify proteins that bind to the cytoplasmic domain of megalin and therefore might be involved in directing megalin Library Screening and DNA Sequencing traffic or signaling. In this article, we report the initial charac- The cDNA encoding the cytoplasmic domain of rat megalin was terization and localization of a novel protein, ANKRA, which obtained by PCR from clone 217 (8) and cloned into the yeast specifically binds to the cytoplasmic domain of megalin. two-hybrid pGBT9 “bait” vector (Clontech). To isolate proteins that interact with the megalin tail, we screened a mouse kidney oligo-dT and random-primed MATCHMAKER cDNA library (Clontech) using Materials and Methods the yeast two-hybrid system as described previously (27,28). Of 5 cDNA and Antibodies million transformants, three scored positive (blue) during lacZ selec- Two incomplete expressed sequence tags (ESTs) of human tion and were found to be identical by restriction digest grouping and ANKRA were obtained from the I.M.A.G.E. Consortium (Washing- sequencing the 5' ends. The insert contained the C-terminal half of ton University-Merck EST project, L. Hillier, unpublished data) and ANKRA (bp 745 to 1774) encoding aa138 to 312, the 3'UTR, and the sequenced by automated DNA sequencing. A complete human cDNA poly-A tail. To obtain the full-length cDNA, a mouse pituitary random sequence (1507 bp long) including the poly A tail was assembled from primed ␭gt-11 cDNA library (custom made by Stratagene and ob- overlapping human ESTs (GenBank accession numbers aa418089, tained from G. M. Rosenfeld, University of California San Diego) was aa442702, N6431, and AW079850). A plasmid containing the entire screened with a cDNA probe encoding aa138 to 312 of ANKRA sequence of human low-density lipoprotein receptor related protein according to the library manufacturer’s instructions. Three clones (LRP) was obtained from Joachim Herz (University of Texas were obtained: clone 11 encoded bp 1 to 1646 of ANKRA including Southwestern). the 5'UTR and 3'UTR, and clones 2 (full-length) and 3 (partial) were Rabbit megalin antiserum (459) was raised against a peptide from alternatively spliced in the C-terminus and 3'UTR, respectively. the cytoplasmic tail of megalin as described (21). Mouse monoclonal Clones were sequenced by either the dideoxynucleotide chain-termi- (mAb) anti-megalin IgG 20B was prepared as described previously nation method with Sequenase (United States Biochemical, Cleve- ␤ (22). Polyclonal anti- 1 integrin (130) was a generous gift from land, OH) or automated sequencing (DNA Sequencing Facility, Richard O. Hynes (MIT). The following antibodies were purchased: Scripps Research Institute, San Diego, CA). anti-HA mAb (BAbCO), goat anti-rabbit or goat anti-mouse IgG conjugated to horseradish peroxidase (HRP; Pierce, Rockford, IL), Amino Acid Sequence Analysis and Northern and cross-absorbed goat anti-rabbit Alexa 488 or anti-mouse Alexa Blot Analysis 594 F(ab')2 (Molecular Probes, Eugene, OR). Antisera were raised in rabbits against purified histidine (His)- On-line BLAST searches were performed via the National Center tagged full-length ANKRA and were affinity purified by coupling for Biotechnology Information at the National Institutes of Health purified His-tagged ANKRA (1-181) to AffiGel 15 beads (BioRad, (Bethesda, MD) (27). Scans for biologically significant sites, patterns, Hercules, CA) according to the manufacturer’s instructions. Bound and localization motifs on ANKRA were performed on-line using IgG was eluted with 0.1 M glycine (pH 2.5). By immunoblotting, 0.6 PROSITE (Swiss-Institute of Bioinformatics) and PSORT (Institute ␮g/ml affinity-purified anti-ANKRA (1-181) IgG detected 10 ng for Molecular and Cellular Biology, Osaka University, Osaka, Japan). purified His-tagged ANKRA. Sequence alignment was done using Clustal W and MacBoxShade ([email protected]) software programs. A Northern blot from eight murine tissues containing 2 ␮g poly Expression and Purification of Fusion Proteins Aϩ RNA per lane was purchased from Clontech and hybridized with Sequences of mouse ANKRA were subcloned by PCR into 32P-labeled probes prepared as described (28). pET28a(ϩ) vector (Novagen, Madison, WI). His-tagged fusion pro- teins were expressed in BL21(DE3) bacteria (Stratagene, La Jolla, GST-Precipitation Assays from Cell Lysates CA). Because the fusion proteins were insoluble in 1% Tween-20, Mouse ANKRA was subcloned by PCR behind an HA-epitope in they were solubilized from inclusion bodies with 8 M urea (in 20 mM the mammalian expression vector pcDNA3 (Invitrogen, Carlsbad, Tris [pH 7.8], 0.5 M NaCl, and 5 mM Imidazole), bound to Ni-NTA CA).
Recommended publications
  • Ankrd9 Is a Metabolically-Controlled Regulator of Impdh2 Abundance and Macro-Assembly

    Ankrd9 Is a Metabolically-Controlled Regulator of Impdh2 Abundance and Macro-Assembly

    ANKRD9 IS A METABOLICALLY-CONTROLLED REGULATOR OF IMPDH2 ABUNDANCE AND MACRO-ASSEMBLY by Dawn Hayward A dissertation submitted to The Johns Hopkins University in conformity with the requirements of the degree of Doctor of Philosophy Baltimore, Maryland April 2019 ABSTRACT Members of a large family of Ankyrin Repeat Domains proteins (ANKRD) regulate numerous cellular processes by binding and changing properties of specific protein targets. We show that interactions with a target protein and the functional outcomes can be markedly altered by cells’ metabolic state. ANKRD9 facilitates degradation of inosine monophosphate dehydrogenase 2 (IMPDH2), the rate-limiting enzyme in GTP biosynthesis. Under basal conditions ANKRD9 is largely segregated from the cytosolic IMPDH2 by binding to vesicles. Upon nutrient limitation, ANKRD9 loses association with vesicles and assembles with IMPDH2 into rod-like structures, in which IMPDH2 is stable. Inhibition of IMPDH2 with Ribavirin favors ANKRD9 binding to rods. The IMPDH2/ANKRD9 assembly is reversed by guanosine, which restores association of ANKRD9 with vesicles. The conserved Cys109Cys110 motif in ANKRD9 is required for the vesicles-to-rods transition as well as binding and regulation of IMPDH2. ANKRD9 knockdown increases IMPDH2 levels and prevents formation of IMPDH2 rods upon nutrient limitation. Thus, the status of guanosine pools affects the mode of ANKRD9 action towards IMPDH2. Advisor: Dr. Svetlana Lutsenko, Department of Physiology, Johns Hopkins University School of Medicine Second reader:
  • Repeat Proteins Challenge the Concept of Structural Domains

    Repeat Proteins Challenge the Concept of Structural Domains

    844 Biochemical Society Transactions (2015) Volume 43, part 5 Repeat proteins challenge the concept of structural domains Rocıo´ Espada*1, R. Gonzalo Parra*1, Manfred J. Sippl†, Thierry Mora‡, Aleksandra M. Walczak§ and Diego U. Ferreiro*2 *Protein Physiology Lab, Dep de Qu´ımica Biologica, ´ Facultad de Ciencias Exactas y Naturales, UBA-CONICET-IQUIBICEN, Buenos Aires, C1430EGA, Argentina †Center of Applied Molecular Engineering, Division of Bioinformatics, Department of Molecular Biology, University of Salzburg, 5020 Salzburg, Austria ‡Laboratoire de physique statistique, CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France §Laboratoire de physique theorique, ´ CNRS, UPMC and Ecole normale superieure, ´ 24 rue Lhomond, 75005 Paris, France Abstract Structural domains are believed to be modules within proteins that can fold and function independently. Some proteins show tandem repetitions of apparent modular structure that do not fold independently, but rather co-operate in stabilizing structural forms that comprise several repeat-units. For many natural repeat-proteins, it has been shown that weak energetic links between repeats lead to the breakdown of co-operativity and the appearance of folding sub-domains within an apparently regular repeat array. The quasi-1D architecture of repeat-proteins is crucial in detailing how the local energetic balances can modulate the folding dynamics of these proteins, which can be related to the physiological behaviour of these ubiquitous biological systems. Introduction and between repeats, challenging the concept of structural It was early on noted that many natural proteins typically domain. collapse stretches of amino acid chains into compact units, defining structural domains [1]. These domains typically correlate with biological activities and many modern proteins can be described as composed by novel ‘domain arrange- Definition of the repeat-units ments’ [2].
  • A Structural Guide to Proteins of the NF-Kb Signaling Module

    A Structural Guide to Proteins of the NF-Kb Signaling Module

    Downloaded from http://cshperspectives.cshlp.org/ on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press A Structural Guide to Proteins of the NF-kB Signaling Module Tom Huxford1 and Gourisankar Ghosh2 1Department of Chemistry and Biochemistry, San Diego State University, 5500 Campanile Drive, San Diego, California 92182-1030 2Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0375 Correspondence: [email protected] The prosurvival transcription factor NF-kB specifically binds promoter DNA to activate target gene expression. NF-kB is regulated through interactions with IkB inhibitor proteins. Active proteolysis of these IkB proteins is, in turn, under the control of the IkB kinase complex (IKK). Together, these three molecules form the NF-kB signaling module. Studies aimed at charac- terizing the molecular mechanisms of NF-kB, IkB, and IKK in terms of their three-dimen- sional structures have lead to a greater understanding of this vital transcription factor system. F-kB is a master transcription factor that from the perspective of their three-dimensional Nresponds to diverse cell stimuli by activat- structures. ing the expression of stress response genes. Multiple signals, including cytokines, growth factors, engagement of the T-cell receptor, and NF-kB bacterial and viral products, induce NF-kB Introduction to NF-kB transcriptional activity (Hayden and Ghosh 2008). A point of convergence for the myriad NF-kB was discovered in the laboratory of of NF-kB inducing signals is the IkB kinase David Baltimore as a nuclear activity with bind- complex (IKK). Active IKK in turn controls ing specificity toward a ten-base-pair DNA transcription factor NF-kB by regulating pro- sequence 50-GGGACTTTCC-30 present within teolysis of the IkB inhibitor protein (Fig.
  • Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions

    Supp. Table S2: Domains and Protein Families with a Putative Role in Host-Symbiont Interactions

    Supp. Table S2: Domains and protein families with a putative role in host-symbiont interactions. The domains and protein families listed here were included in the comparisons in Figure 5 and Supp. Figure S5, which show the percentage of the respective protein groups in the Riftia symbiont metagenome and in metagenomes of other symbiotic and free-living organisms. % bacterial, total number bacterial: Percentage and total number of bacterial species in which this domain is found in the SMART database (January 2019). Domain name Pfam/SMART % bacterial (total Literature/comment annotation number bacterial) Alpha-2- alpha-2- A2M: 42.05% (2057) A2Ms: protease inhibitors which are important for eukaryotic macroglobulin macroglobulin innate immunity, if present in prokaryotes apparently fulfill a family (A2M), similar role, e.g. protection against host proteases (1) including N- terminal MG1 domain ANAPC Anaphase- APC2: 0 Ubiquitin ligase, important for cell cycle control in eukaryotes (2) promoting complex Bacterial proteins might interact with ubiquitination pathways in subunits the host (3) Ankyrin Ankyrin repeats 10.88% (8348) Mediate protein-protein interactions without sequence specificity (4) Sponge symbiont ankyrin-repeat proteins inhibit amoebal phagocytosis (5) Present in sponge microbiome metatranscriptomes, putative role in symbiont-host interactions (6) Present in obligate intracellular amoeba symbiont Candidatus Amoebophilus asiaticus genome, probable function in interactions with the host (7) Armadillo Armadillo repeats 0.83% (67)
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant

    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
  • WSB1: from Homeostasis to Hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew Macisaac1,2,3 and Douglas James Demetrick1,2,3,4*

    WSB1: from Homeostasis to Hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew Macisaac1,2,3 and Douglas James Demetrick1,2,3,4*

    Haque et al. Journal of Biomedical Science (2016) 23:61 DOI 10.1186/s12929-016-0270-3 REVIEW Open Access WSB1: from homeostasis to hypoxia Moinul Haque1,2,3, Joseph Keith Kendal1,2,3, Ryan Matthew MacIsaac1,2,3 and Douglas James Demetrick1,2,3,4* Abstract The wsb1 gene has been identified to be important in developmental biology and cancer. A complex transcriptional regulation of wsb1 yields at least three functional transcripts. The major expressed isoform, WSB1 protein, is a substrate recognition protein within an E3 ubiquitin ligase, with the capability to bind diverse targets and mediate ubiquitinylation and proteolytic degradation. Recent data suggests a new role for WSB1 as a component of a neuroprotective pathway which results in modification and aggregation of neurotoxic proteins such as LRRK2 in Parkinson’s Disease, via an unusual mode of protein ubiquitinylation. WSB1 is also involved in thyroid hormone homeostasis, immune regulation and cellular metabolism, particularly glucose metabolism and hypoxia. In hypoxia, wsb1 is a HIF-1 target, and is a regulator of the degradation of diverse proteins associated with the cellular response to hypoxia, including HIPK2, RhoGDI2 and VHL. Major roles are to both protect HIF-1 function through degradation of VHL, and decrease apoptosis through degradation of HIPK2. These activities suggest a role for wsb1 in cancer cell proliferation and metastasis. As well, recent work has identified a role for WSB1 in glucose metabolism, and perhaps in mediating the Warburg effect in cancer cells by maintaining the function of HIF1. Furthermore, studies of cancer specimens have identified dysregulation of wsb1 associated with several types of cancer, suggesting a biologically relevant role in cancer development and/or progression.
  • Structural and Biochemical Consequences of Disease-Causing Mutations in the Ankyrin Repeat Domain of the Human TRPV4 Channel

    Structural and Biochemical Consequences of Disease-Causing Mutations in the Ankyrin Repeat Domain of the Human TRPV4 Channel

    Structural and Biochemical Consequences of Disease-Causing Mutations in the Ankyrin Repeat Domain of the Human TRPV4 Channel The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Inada, Hitoshi, Erik Procko, Marcos Sotomayor, and Rachelle Gaudet. 2012. Structural and biochemical consequences of disease- causing mutations in the ankyrin repeat domain of the human TRPV4 channel. Biochemistry 51(31): 6195-6206. Published Version doi:10.1021/bi300279b Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11688820 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel Hitoshi Inada†, Erik Procko†,‡, Marcos Sotomayor†,§, and Rachelle Gaudet†,* †Department of Molecular and Cellular Biology, Harvard University, 52 Oxford Street, Cambridge, MA 02138 ‡Present address: Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, WA 98195, USA §Howard Hughes Medical Institute and Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA AUTHOR EMAIL ADDRESS: [email protected] TITLE RUNNING HEAD: Structural analysis of human TRPV4-ARD CORRESPONDING AUTHOR FOOTNOTE: *To whom correspondence should be addressed: Rachelle Gaudet, Department of Molecular and Cellular Biology, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA, Tel.: (617) 495-5616; Fax: (617) 496-9684; E-mail: [email protected] FOOTNOTES: This work was funded by NIH grant R01GM081340 to RG.
  • Dissecting and Reprogramming the Folding and Assembly of Tandem-Repeat Proteins

    Dissecting and Reprogramming the Folding and Assembly of Tandem-Repeat Proteins

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Apollo Dissecting and reprogramming the folding and assembly of tandem-repeat proteins Pamela J.E. Rowling1, Elin M. Sivertsson1, Albert Perez-Riba1, Ewan R. G. Main2*, Laura S. Itzhaki1* 1University of Cambridge Department of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK. 2School of Biological and Chemical Sciences, Queen Mary, University of London, London E1 4NS, UK. *To whom correspondence should be addressed: [email protected] and [email protected] Studying protein folding and protein design in globular proteins presents significant challenges because of the two related features, topological complexity and cooperativity. In contrast, tandem-repeat proteins have regular and modular structures composed of linearly arrayed motifs. This means that the biophysics of even giant repeat proteins is highly amenable to dissection and to rational design. Here we discuss what has been learnt about the folding mechanisms of tandem- repeat proteins. The defining features that have emerged are: (i) accessibility of multiple distinct routes between denatured and native states, both at equilibrium and under kinetic conditions; (ii) different routes are favoured for folding versus unfolding; (iii) unfolding energy barriers are broad, reflecting stepwise unraveling of an array repeat by repeat; (iv) highly cooperative unfolding at equilibrium and the potential for exceptionally high thermodynamic stabilities by introducing consensus residues; (v) under force, helical-repeat structures are very weak with non-cooperative unfolding leading to elasticity and buffering effects. This level of understanding should enable us to create repeat proteins with made-to-measure folding mechanisms, in which one can dial into the sequence the order of repeat folding, number of pathways taken, step size (cooperativity) and fine-structure of the kinetic energy barriers.
  • Take Home Lessons from Studies of Related Proteins

    Take Home Lessons from Studies of Related Proteins

    Available online at www.sciencedirect.com Take home lessons from studies of related proteins * Adrian A Nickson, Beth G Wensley and Jane Clarke The ‘Fold Approach’ involves a detailed analysis of the folding The malleability of protein folding pathways of several topologically, structurally and/or evolutionarily A unifying folding mechanism related proteins. Such studies can reveal determinants of the In the early days of the ‘protein-folding problem’, three folding mechanism beyond the gross topology, and can dissect competing mechanisms were proposed that described the residues required for folding from those required for stability how a polypeptide chain might fold to the native state: or function. While this approach has not yet matured to the nucleation [3], hydrophobic-collapse [4] and diffusion- point where we can predict the native conformation of any collision (framework) [5]. However, an early F-value polypeptide chain in silico, it has been able to highlight, analysis of the small protein chymotrypsin inhibitor 2 amongst others, the specific residues that are responsible for (CI2) demonstrated that none of these mechanisms was nucleation, pathway malleability, kinetic intermediates, chain appropriate, since secondary and tertiary structure formed knotting, internal friction and Paracelsus switches. Some of the concomitantly [6]. Thus the nucleation-condensation most interesting discoveries have resulted from the attempt to mechanism was introduced [7], in which long-range con- explain differences between homologues. tacts set up the initial topology of the protein (incurring a Address substantial entropic loss with minimal enthalpic gain), Department of Chemistry, University of Cambridge, Lensfield Rd, followed by a rapid collapse to the native state (with Cambridge CB2 1EW, UK minimal entropic loss but substantial enthalpic gain).
  • (TRP) Cation Channels Could Explain Smell, Taste, And/Or Chemesthesis Disorders

    (TRP) Cation Channels Could Explain Smell, Taste, And/Or Chemesthesis Disorders

    Interactions of SARS-CoV-2 spike protein and transient receptor potential (TRP) cation channels could explain smell, taste, and/or chemesthesis disorders Halim Maaroufi Institut de biologie intégrative et des systèmes (IBIS). Université Laval. Quebec city, Quebec, Canada. [email protected] IN BRIEF SARS-CoV-2 S protein contains two ankyrin repeat binding motifs (S-ARBMs) that could interact with ankyrin repeat domains (ARDs) of transient receptor potential (TRP) channels. The latter play a role in olfaction, taste, and/or chemesthesis (OTC), suggesting that their dysfunction by S protein could explain OTC disorders in COVID-19 disease. Pharmacological manipulation of TRPs-ARDs could be used for prophylactic or treatments in SARS-CoV-2 infections. HIGHLIGHTS SARS-CoV-2 infection is associated to olfactory, taste, and/or chemesthesis (OTC) disorders (OTCD). Transient receptor potential (TRP) channels play a role in OTC. S protein contains ARBMs that could interact with ARDs of TRPs, thus inducing OTCD. TRPs ligands as possible preventive treatments against COVID-19. KEYWORDS Loss, Olfactory, Taste, Chemesthesis, SARS-CoV-2, S protein, Ankyrin repeat, Ankyrin repeat binding motif, TRPA1, TRPCs, TRPVs, TRPs ligands, DARPins ABBREVIATIONS SARS-CoV-2: severe acute respiratory syndrome coronavirus 2 COVID-19: Coronavirus disease-2019 S protein: Spike protein 1 RBD: Receptor binding domain HR1: Heptad repeat 1 OTC: olfactory, taste and chemesthesis OTCD: olfactory, taste and/or chemesthesis disorders TRP: Transient receptor potential
  • The Contribution of the Ankyrin Repeat Domain of TRPV1 As a Thermal

    The Contribution of the Ankyrin Repeat Domain of TRPV1 As a Thermal

    bioRxiv preprint doi: https://doi.org/10.1101/641803; this version posted May 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The contribution of the ankyrin repeat 2 domain of TRPV1 as a thermal module 3 4 E. Ladrón-de-Guevara 5 G. E. Rangel-Yescas 6 D. A. Fernández-Velasco 7 A. Torres-Larios 8 T. Rosenbaum 9 L. D. Islas 10 11 Abstract 12 The TRPV1 cation non-selective ion channel plays an essential role in thermosensation and perception of 13 other noxious stimuli. TRPV1 can be activated by low pH, high temperature or naturally occurring 14 pungent molecules such as allicin, capsaicin or resiniferatoxin. Its noxious thermal sensitivity makes it an 15 important participant as a thermal sensor in mammals. However, details of the mechanism of channel 16 activation by increases in temperature remain unclear. Here we used a combination of approaches to try 17 to understand the role of the ankyrin repeat domain (ARD) in channel behavior. First, a computational 18 modeling approach by coarse-grained molecular dynamics simulation of the whole TRPV1 embedded in 19 a phosphatidylcholine (POPC) and phosphatidylethanolamine (POPE) membrane provides insight into 20 the dynamics of this channel domain. Global analysis of the structural ensemble shows that the ankyrin 21 repeat domain is a region that sustains high fluctuations during dynamics at different temperatures. We 22 then performed biochemical and thermal stability studies of the purified ARD by means of circular 23 dichroism and tryptophan fluorescence and demonstrate that this region undergoes structural changes 24 at similar temperatures that lead to TRPV1 activation.
  • Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways

    Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways

    Provided for non-commercial research and educational use only. Not for reproduction, distribution or commercial use. This chapter was originally published in the book Progress in Molecular Biology and Translational Science, Vol. 84, published by Elsevier, and the attached copy is provided by Elsevier for the author's benefit and for the benefit of the author's institution, for non-commercial research and educational use including without limitation use in instruction at your institution, sending it to specific colleagues who know you, and providing a copy to your institution’s administrator. All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are prohibited. For exceptions, permission may be sought for such use through Elsevier's permissions site at: http://www.elsevier.com/locate/permissionusematerial From: Anna L. Mallam and Sophie E. Jackson, Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways. In P. Michael Conn, editor: Progress in Molecular Biology and Translational Science, Vol. 84, Burlington: Academic Press, 2008, pp. 57-113. ISBN: 978-0-12-374595-8 © Copyright 2008 Elsevier Inc. Academic Press. Author's personal copy Use of Protein Engineering Techniques to Elucidate Protein Folding Pathways Anna L. Mallam and Sophie E. Jackson Department of Chemistry, Cambridge, CB2 1EW, United Kingdom I. Introduction............................................................................... 58 II. Early Protein Engineering Studies of Folding Pathways ........................ 59 III. Single Point Mutations and F‐Value Analysis...................................... 61 A. Mixed a/b Proteins .................................................................. 65 B. All‐a‐Helical Proteins............................................................... 69 C. All‐b‐Proteins........................................................................